| Caris Life Sciences, Inc. | CAI | 7.82M | $210.9M | 6.7% | — | Held |
| Guardant Health, Inc. | GH | 104.9M | $192.3M | 6.2% | — | Held |
| Edgewise Therapeutics, Inc. | EWTX | 5.21M | $129.3M | 4.1% | — | Held |
| Repligen Corp | RGEN | 101M | $110.8M | 3.5% | — | Held |
| Neurocrine Biosciences Inc | NBIX | 751.5K | $106.6M | 3.4% | — | Held |
| Glaukos Corp | GKOS | 922K | $104.1M | 3.3% | — | Held |
| Neogenomics Inc | NEO | 100.4M | $89.7M | 2.9% | — | Held |
| Nuvalent Inc | — | 821.4K | $82.6M | 2.6% | — | Held |
| Xenon Pharmaceuticals Inc. | XENE | 1.83M | $81.8M | 2.6% | — | Held |
| CG Oncology, Inc. | CGON | 1.87M | $77.7M | 2.5% | — | Held |
| Irhythm Technologies Inc | IRTC | 52M | $72.8M | 2.3% | — | Held |
| Hinge Health, Inc. | HNGE | 1.3M | $60.6M | 1.9% | — | Held |
| Align Technology Inc | ALGN | 381K | $59.5M | 1.9% | — | Held |
| Kodiak Sciences Inc. | KOD | 2.07M | $58M | 1.9% | — | Held |
| Soleno Therapeutics Inc | — | 1.19M | $55M | 1.8% | — | Held |
| Centessa Pharmaceuticals Plc | — | 2.19M | $54.7M | 1.8% | — | Held |
| Neogenomics Inc | NEO | 4.63M | $54.5M | 1.7% | — | Held |
| Acadia Pharmaceuticals Inc | ACAD | 2.03M | $54.3M | 1.7% | — | Held |
| Spyre Therapeutics, Inc. | SYRE | 1.63M | $53.5M | 1.7% | — | Held |
| Dianthus Therapeutics Inc | — | 1.27M | $52.5M | 1.7% | — | Held |
| Ironwood Pharmaceuticals Inc | IRWD | 53.4M | $50.5M | 1.6% | — | Held |
| Celldex Therapeutics Inc New | — | 1.86M | $50.5M | 1.6% | — | Held |
| Inspire Med Sys Inc | — | 540.9K | $49.9M | 1.6% | — | Held |
| Krystal Biotech, Inc. | KRYS | 202.1K | $49.8M | 1.6% | — | Held |
| Intuitive Surgical Inc | ISRG | 83.4K | $47.2M | 1.5% | — | Held |
| Thermo Fisher Scientific Inc. | TMO | 80.7K | $46.8M | 1.5% | — | Held |
| Brightspring Health Svcs Inc | — | 1.2M | $44.8M | 1.4% | — | Held |
| Cvs Health Corp | CVS | 564.2K | $44.8M | 1.4% | — | Held |
| Apogee Therapeutics, Inc. | APGE | 575.1K | $43.4M | 1.4% | — | Held |
| Nurix Therapeutics, Inc. | NRIX | 2.18M | $41.4M | 1.3% | — | Held |
| Vera Therapeutics, Inc. | VERA | 784.7K | $39.7M | 1.3% | — | Held |
| Irhythm Technologies Inc | IRTC | 217.3K | $38.6M | 1.2% | — | Held |
| TransMedics Group, Inc. | TMDX | 315.3K | $38.4M | 1.2% | — | Held |
| Biomarin Pharmaceutical Inc | BMRN | 601.5K | $35.7M | 1.1% | — | Held |
| Illumina, Inc. | ILMN | 269.7K | $35.4M | 1.1% | — | Held |
| Kymera Therapeutics, Inc. | KYMR | 454.3K | $35.3M | 1.1% | — | Held |
| Fulcrum Therapeutics, Inc. | FULC | 3.06M | $34.6M | 1.1% | — | Held |
| Penumbra Inc | PEN | 110.2K | $34.2M | 1.1% | — | Held |
| MBX Biosciences, Inc. | MBX | 1.02M | $32.1M | 1.0% | — | Held |
| Rapt Therapeutics Inc | — | 929.7K | $31.5M | 1.0% | — | Held |
| CareDx, Inc. | CDNA | 1.59M | $29.9M | 1.0% | — | Held |
| Dyne Therapeutics, Inc. | DYN | 1.48M | $28.9M | 0.9% | — | Held |
| Engene Holdings Inc | — | 3.13M | $28.3M | 0.9% | — | Held |
| Legend Biotech Corp | LEGN | 1.3M | $28.2M | 0.9% | — | Held |
| Maravai Lifesciences Hldgs I | — | 8.35M | $27.1M | 0.9% | — | Held |
| Danaher Corporation | — | 118.2K | $27.1M | 0.9% | — | Held |
| Argenx SE | ARGX | 31K | $26.1M | 0.8% | — | Held |
| Natera, Inc. | NTRA | 111.5K | $25.5M | 0.8% | — | Held |
| Bright Minds Biosciences Inc. | DRUG | 324.4K | $25.3M | 0.8% | — | Held |
| Terns Pharmaceuticals Inc | — | 575.3K | $23.2M | 0.7% | — | Held |
| Evolus, Inc. | EOLS | 3.11M | $20.6M | 0.7% | — | Held |
| Biogen Inc. | BIIB | 115.7K | $20.4M | 0.7% | — | Held |
| Orthopediatrics Corp | KIDS | 1.1M | $19.5M | 0.6% | — | Held |
| Tectonic Therapeutic, Inc. | TECX | 927.5K | $19.3M | 0.6% | — | Held |
| Ventyx Biosciences Inc | — | 1.92M | $17.3M | 0.6% | — | Held |
| Zura Bio Ltd | ZURA | 3.18M | $16.7M | 0.5% | — | Held |
| Compass Therapeutics, Inc. | CMPX | 2.79M | $15M | 0.5% | — | Held |
| Monte Rosa Therapeutics, Inc. | GLUE | 948.3K | $14.9M | 0.5% | — | Held |
| Harrow, Inc. | HROW | 295.3K | $14.5M | 0.5% | — | Held |
| X4 Pharmaceuticals, Inc | XFOR | 3.37M | $13.5M | 0.4% | — | Held |
| Repligen Corp | RGEN | 81.8K | $13.4M | 0.4% | — | Held |
| Icon Plc | ICLR | 73.4K | $13.4M | 0.4% | — | Held |
| Kiniksa Pharmaceuticals Intl | — | 313.8K | $12.9M | 0.4% | — | Held |
| GRAIL, Inc. | GRAL | 142.8K | $12.2M | 0.4% | — | Held |
| Surrozen Inc | — | 470K | $10.6M | 0.3% | — | Held |
| Relmada Therapeutics, Inc. | RLMD | 1.58M | $7.64M | 0.2% | — | Held |
| Xencor Inc | XNCR | 459.2K | $7.03M | 0.2% | — | Held |
| Castle Biosciences Inc | CSTL | 177.2K | $6.89M | 0.2% | — | Held |
| Adaptive Biotechnologies Cor | — | 312K | $5.07M | 0.2% | — | Held |
| BillionToOne, Inc. | BLLN | 50K | $4.09M | 0.1% | — | Held |
| Oruka Therapeutics, Inc. | ORKA | 84.8K | $2.57M | 0.1% | — | Held |
| Karyopharm Therapeutics Inc. | KPTI | 303.4K | $2.23M | 0.1% | — | Held |
| Pulmonx Corp | LUNG | 752.5K | $1.66M | 0.1% | — | Held |